Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berhe

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical and Experimental Immunology|October 23, 2002
Alteration of Fas and Fas ligand expression during human visceral leishmaniasisL Eidsmo, D Wolday, N Berhe, et al.
The Journal of Infectious Diseases|June 9, 2001
Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cureA Hailu, J N Menon, N Berhe, et al.
AIDS (London, England)|October 8, 1999
HIV viral load and response to antileishmanial chemotherapy in co-infected patientsN Berhe, D Wolday, A Hailu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical and Experimental Immunology|October 23, 2002
Alteration of Fas and Fas ligand expression during human visceral leishmaniasisL Eidsmo, D Wolday, N Berhe, et al.
The Journal of Infectious Diseases|June 9, 2001
Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cureA Hailu, J N Menon, N Berhe, et al.
AIDS (London, England)|October 8, 1999
HIV viral load and response to antileishmanial chemotherapy in co-infected patientsN Berhe, D Wolday, A Hailu, et al.
Pageof 3